Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ret finger protein-like 4A pseudogene 4 (RFPL4AP4) is a human processed pseudogene, located at ENSG00000270387, that resembles the protein-coding gene RFPL4A but is regarded as non-coding[1][7][9]. Despite lacking protein-coding capability, RFPL4AP4 may have important biological roles, such as acting as a competitive endogenous RNA/microRNA sponge to regulate gene expression[2]. Recent data indicates that overexpression of RFPL4AP4 (RPL4P4) is significantly associated with glioma progression, poor clinical outcomes, increased tumor grade, and changes in the tumor immune microenvironment, specifically the infiltration of M2-type macrophages[2]. Knockdown of RFPL4AP4 inhibits glioma cell proliferation, migration, and invasion in cell models, suggesting regulatory involvement in tumorigenesis and the tumor microenvironment[2]. However, as a pseudogene, it is not classified as a therapeutic target such as a receptor, enzyme, transporter, or transcription factor. Its clinical utility currently lies in its potential function as a prognostic biomarker in glioma rather than a direct therapeutic target[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ret finger protein-like 4A pseudogene 4 (RFPL4AP4).